Results 31 to 40 of about 10,710,575 (236)

High expression of Linc00959 predicts poor prognosis in breast cancer

open access: yesCancer Cell International, 2019
Background Accumulating studies have focused on the oncogenic roles of the newly identified lncRNAs in human cancers. The aim of this study was to examine the expression pattern of Linc00959 in BC and to evaluate its biological role and clinical ...
Weiru Chi   +6 more
doaj   +1 more source

The Practice Patterns and Perceptions of Korean Surgeons Regarding Margin Status after Breast-Conserving Surgery [PDF]

open access: yes, 2017
Two consecutive surveys for breast surgeons in Korea were conducted to comprehend the practice patterns and perceptions on margin status after breast-conserving surgery. The surveys were conducted online in 2014 (initial) and 2016 (follow-up). A total of
안성귀
core   +1 more source

Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations [PDF]

open access: yes, 2021
Purpose: Li-Fraumeni syndrome (LFS) is a rare autosomal cancer syndrome caused by a germline mutation in the TP53 gene. Breast cancer in LFS patients is of various subtypes; however, limited data are available on the clinicopathological features of these
정준   +14 more
core   +1 more source

Breast cancer: pathogenesis and treatments

open access: yesSignal Transduction and Targeted Therapy
Breast cancer, characterized by unique epidemiological patterns and significant heterogeneity, remains one of the leading causes of malignancy-related deaths in women.
Xin Xiong   +9 more
semanticscholar   +1 more source

NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.

open access: yesThe Journal of the National Comprehensive Cancer Network, 2023
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly.
W. Gradishar   +36 more
semanticscholar   +1 more source

Association of genetic variants at 8q24 with breast cancer risk. [PDF]

open access: yes, 2008
Recent whole genome association studies of prostate, breast, and colorectal cancer have identified susceptibility loci on 8q24. We genotyped three variants associated with prostate cancer (rs10090154, rs13254738, and rs7000448), one associated with both ...
Johnson, Nichola   +9 more
core   +1 more source

Expert consensus on diagnosis, treatment and fertility management of young breast cancer patients

open access: yesJournal of the National Cancer Center, 2021
Breast cancer in young females is a relatively common disease in China. Young breast cancer has aggressive clinical and pathological features. During the treatment of young females with breast cancer, issues involving the choice of surgical methods ...
Committee of Diagnosis, Treatment, and Fertility Management of Chinese Young Breast Cancer Patients
doaj   +1 more source

Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

open access: yesMolecular Cancer, 2023
Breast cancer is the second leading cause of death for women worldwide. The heterogeneity of this disease presents a big challenge in its therapeutic management.
Feng Ye   +9 more
semanticscholar   +1 more source

Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is down-regulated in metaplastic breast cancer [PDF]

open access: yes, 2017
Purpose We have previously described a novel pathway controlling drug resistance, epithelial-to-mesenchymal transition (EMT) and stemness in breast cancer cells.
Singh, P   +12 more
core   +1 more source

Immunotherapy in breast cancer: an overview of current strategies and perspectives

open access: yesnpj Breast Cancer, 2023
Recent progress in immunobiology has led the way to successful host immunity enhancement against breast cancer. In triple-negative breast cancer, the combination of cancer immunotherapy based on PD-1/PD-L1 immune checkpoint inhibitors with chemotherapy ...
V. Debien   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy